Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib
Individual Patient Program for Patient With Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib
Sponsor: Jonsson Comprehensive Cancer Center
A observational or N/A phase clinical study on Progressive Metastatic Castrate Resistant Prostate Cancer, this trial is ongoing. The trial is conducted by Jonsson Comprehensive Cancer Center and has accumulated 7 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Jan 2021 — Jul 2024 [monthly]
No Longer Available
-
Feb 2019 — Jan 2021 [monthly]
No Longer Available
Status: Available → No Longer Available
-
Jun 2018 — Feb 2019 [monthly]
Available
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Available
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Available NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jonsson Comprehensive Cancer Center
- Novartis
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.